Haruka Tsuchiya, Mineto Ota, Haruka Takahashi, Hiroaki Hatano, Megumi Ogawa, Sotaro Nakajima, . . . Keishi Fujio. (2024). Epigenetic targets of Janus kinase inhibitors are linked to genetic risks of rheumatoid arthritis. BMC.
Chicago Style (17th ed.) CitationHaruka Tsuchiya, et al. Epigenetic Targets of Janus Kinase Inhibitors Are Linked to Genetic Risks of Rheumatoid Arthritis. BMC, 2024.
MLA (9th ed.) CitationHaruka Tsuchiya, et al. Epigenetic Targets of Janus Kinase Inhibitors Are Linked to Genetic Risks of Rheumatoid Arthritis. BMC, 2024.
Warning: These citations may not always be 100% accurate.